Peptide‐Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by … M Castelli, F Cappelletti, RA Diotti, G Sautto, E Criscuolo, M Dal Peraro, ... Journal of Immunology Research 2013 (1), 521231, 2013 | 39 | 2013 |
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes N Clementi, E Criscuolo, F Cappelletti, R Burioni, M Clementi, N Mancini Drug discovery today 21 (4), 682-691, 2016 | 19 | 2016 |
Role and potential therapeutic use of antibodies against herpetic infections N Clementi, F Cappelletti, E Criscuolo, M Castelli, N Mancini, R Burioni, ... Clinical Microbiology and Infection 23 (6), 381-386, 2017 | 16 | 2017 |
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity F Cappelletti, N Clementi, N Mancini, M Clementi, R Burioni Seminars in immunology 27 (2), 138-143, 2015 | 14 | 2015 |
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy RA Diotti, N Mancini, N Clementi, G Sautto, GJ Moreno, E Criscuolo, ... Antiviral Research 108, 94-103, 2014 | 14 | 2014 |
Entry inhibition of HSV-1 and-2 protects mice from viral lethal challenge N Clementi, E Criscuolo, F Cappelletti, P Quaranta, M Pistello, RA Diotti, ... Antiviral research 143, 48-61, 2017 | 11 | 2017 |
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis N Clementi, N Mancini, E Criscuolo, F Cappelletti, M Clementi, R Burioni Monoclonal Antibodies: Methods and Protocols, 427-446, 2014 | 10 | 2014 |
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice M Retamal, Y Abed, C Rhéaume, F Cappelletti, N Clementi, N Mancini, ... Antimicrobial Agents and Chemotherapy 59 (5), 2647-2653, 2015 | 2 | 2015 |
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 E Criscuolo, F Cappelletti, N Clementi, RA Diotti, M Castelli, N Mancini, ... ABSTRACT BOOK 3° ITALIAN EXPERIENCE IN BIOMEDICAL RESEARCH: YOUNG MINDS AT WORK, 2015 | | 2015 |
Human monoclonal antibody endowed with anti-HSV-1 and-2 activity strongly inhibits virus replication F Cappelletti, E Criscuolo, N Clementi, G Sautto, V Caputo, N Mancini, ... 3rd Italian experience in biomedical research: young minds at work, 65-65, 2015 | | 2015 |
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses E Criscuolo, F Cappelletti, N Clementi, N Mancini, G Sautto, R Diotti, ... ICI–International Congress of Immunology, 2013 | | 2013 |
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies E Criscuolo, F Cappelletti, G Sautto, R Diotti, N Clementi, N Mancini, ... 3rd EUSPM Congress, 2013 | | 2013 |
Broadly anti-hepatitis C virus (HCV) cross-neutralizing monoclonal antibodies (mAbs) directed against the HCV/E2 glycoprotein and not subjected to Ab-mediated interference GA Sautto, N Mancini, G Gorini, RA Diotti, N Clementi, E Criscuolo, ... Front. Immunol. Conference Abstract: 15th International Congress of …, 2013 | | 2013 |
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome E Criscuolo, F Cappelletti, GA Sautto, RA Diotti, N Clementi, N Mancini, ... Clinical Biochemistry 12 (46), 1157-1157, 2013 | | 2013 |